Elamipretide
Also called SS-31, bendavia, MTP-131
- Evidence
- Approved drug evidence
- Class
- Mitochondria-targeting tetrapeptide
Elamipretide belongs to the Mitochondria-targeting tetrapeptide class. This library groups it under hormones & metabolism. Its source category is In clinical trials.
At a glance
| Compound class | Mitochondria-targeting tetrapeptide |
|---|---|
| Body system | Hormones & metabolism |
| Use or research focus | Barth syndrome; mitochondrial disease |
| Regulatory status | Investigational (FDA review/refiled) |
| Source evidence rating | Approved drug evidence |
How does Elamipretide work?
Stabilizes cardiolipin; improves mitochondrial function.
The source catalog maps this mechanism to Mitochondria, Heart / Cardiovascular. A biological mechanism describes how a compound interacts with the body; it does not by itself prove a clinical benefit.
What does the evidence tell us?
This record is associated with evidence for an approved drug. Approval applies to a specific formulation and indication; it does not extend to every use, combination, or compounded preparation. Check the regulatory details and linked prescribing information.
Use the Citations tab to examine the underlying sources. Look for human studies, a relevant comparison group, meaningful outcomes, and adequate follow-up. An ingredient, approved drug, and compounded preparation may have different evidence.
Safety and considerations
A compound being studied in a clinical trial is not necessarily approved or effective. Trial participants follow a study protocol with eligibility criteria and monitoring. Results from one population or formulation may not apply to another.
This library is educational and does not provide dosing or treatment instructions. A listing here does not indicate that Peppy offers the compound.
Common questions
What is Elamipretide?
Elamipretide belongs to the Mitochondria-targeting tetrapeptide class. This library groups it under hormones & metabolism. Its source category is In clinical trials. Its recorded use or research focus is: Barth syndrome; mitochondrial disease.
Is Elamipretide FDA-approved?
The catalog records: Investigational (FDA review/refiled). Check the current product-specific regulatory information in the source links; a source category does not establish approval for every use or formulation.
How strong is the research?
This record is associated with evidence for an approved drug. Approval applies to a specific formulation and indication; it does not extend to every use, combination, or compounded preparation. Check the regulatory details and linked prescribing information.
Where can I read the research?
The Citations tab contains 3 reference links from the source dataset. The original research guide provides additional context. These links are a starting point for reading the evidence.
More for hormones & metabolism
Factual catalog fields and citation links are adapted from Superpower’s Elamipretide guide and the public dataset linked in the reference post. Peppy’s explanations are educational; this page does not represent an independent clinical review of every linked study.
Sources & further reading
References associated with Elamipretide in the source dataset. Open a source to review its study design, population, limitations, and date.
View the original research guide